Silicon Valley Capital Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$109K Buy
589
+16
+3% +$2.97K 0.01% 101
2025
Q1
$118K Buy
573
+56
+11% +$11.5K 0.02% 96
2024
Q4
$91.8K Sell
517
-198
-28% -$35.2K 0.01% 107
2024
Q3
$141K Sell
715
-6
-0.8% -$1.18K 0.02% 85
2024
Q2
$124K Sell
721
-41
-5% -$7.03K 0.02% 87
2024
Q1
$139K Sell
762
-158
-17% -$28.8K 0.02% 77
2023
Q4
$143K Sell
920
-132
-13% -$20.5K 0.02% 74
2023
Q3
$157K Sell
1,052
-105
-9% -$15.6K 0.03% 70
2023
Q2
$156K Sell
1,157
-100
-8% -$13.5K 0.03% 75
2023
Q1
$200K Sell
1,257
-62
-5% -$9.88K 0.04% 68
2022
Q4
$213K Buy
+1,319
New +$213K 0.05% 66
2022
Q3
Sell
-1,475
Closed -$226K 66
2022
Q2
$226K Sell
1,475
-49
-3% -$7.51K 0.05% 58
2022
Q1
$247K Buy
1,524
+8
+0.5% +$1.3K 0.04% 64
2021
Q4
$205K Buy
+1,516
New +$205K 0.03% 75
2021
Q2
Sell
-1,978
Closed -$214K 62
2021
Q1
$214K Sell
1,978
-114
-5% -$12.3K 0.05% 64
2020
Q4
$224K Buy
+2,092
New +$224K 0.05% 56